Propanc Biopharma, Inc. GAAP EPS of -$0.30
Source: SeekingAlpha
2026-02-18 15:42:43 ET
More on Propanc Biopharma, Inc.
- Seeking Alpha’s Quant Rating on Propanc Biopharma, Inc.
- Financial information for Propanc Biopharma, Inc.
Read the full article on Seeking Alpha
For further details see:
Propanc Biopharma, Inc. GAAP EPS of -$0.30
Propanc Biopharma Inc
NASDAQ: PPCB
PPCB Trading
61.54% G/L:
$2.87 Last:
496,164 Volume:
$4 Open:
PPCB Latest News
March 10, 2026 08:45:00 am
Propanc Biopharma Executes Service Agreement with FyoniBio to Establish & Validate Pharmacokinetics Assay for Phase 1b First-In-Human Study
March 03, 2026 08:45:00 am
Propanc Biopharma's Lead Asset PRP Shows >85% Tumor Growth Inhibition in Preclinical Pancreatic Models
February 18, 2026 08:45:00 am
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
PPCB Stock Data
$2,843,169
6,741,209
N/A
5
N/A
Biotechnology & Life Sciences
Healthcare
AU
Camberwell
